Advertisement

Topics

Latest "FREDsense Technologies Corp." News Stories

06:50 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "FREDsense Technologies Corp." found in our extensive news archives from over 250 global news sources.

More Information about FREDsense Technologies Corp. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about FREDsense Technologies Corp. for you to read. Along with our medical data and news we also list FREDsense Technologies Corp. Clinical Trials, which are updated daily. BioPortfolio also has a large database of FREDsense Technologies Corp. Companies for you to search.

Showing "FREDsense Technologies Corp" News Articles 1–25 of 4,600+

Sunday 17th February 2019

Global UAV Autopilot Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global UAV Autopilot market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included based on manufacturin...


Friday 15th February 2019

Company Profile for Novus Therapeutics, Inc.

Novus Therapeutics, Inc. (“Novus”) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. Novus’ lead product candidate (OP0201) is a surfactant-based, drug-device co...

New project explores how gaming technologies can help cancer patients communicate better

Lancaster University is sharing in a €4m project to use gaming technology to improve the care of both adults and children with cancer.


Vivacelle Bio, Inc. Receives FDA Clearance to Enroll Patients into its Phase IIa Clinical Trial of VBI-1 for Severe Blood Loss and/or Raising Blood Pressure in Hypovolemic Subjects

Vivacelle Bio, Inc. today announces that the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular support fluid that is designed for the treatment of patients with emergently life-threate...

Taronis Technologies (MNGA) - Good start to FY19 sales

Edison Investment Research - General Industrials - Taronis Technologies: Taronis Technologies (formerly MagneGas) has announced its preliminary sales figures for January. These show the seven successive acquisitions made over the last year driving a fivefold year-on-year increase in monthly sales to $1.42m. Importantly, the figures show 42% growth compared with December, as activity has picked up ...

The Biotech Growth Trust (BIOG) - Industry backdrop remains favourable

Edison Investment Research - Investment trusts - The Biotech Growth Trust: The Biotech Growth Trust (BIOG) is managed by Geoff Hsu and Richard Klemm at OrbiMed Capital, one of the leading global healthcare asset managers. The year 2018 proved to be tough for the trust’s performance as biotech companies delivering negative news were heavily penalised, while those delivering good news went unr...

Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M

A developer of gene therapies for rare monogenic CNS diseases—whose co-founders include pioneer researcher James M. Wilson, MD, PhD—has launched with $115.5 million in Series A financing. Passage Bio said it will use proceeds from the financing to develop a portfolio of five therapeutic candidates that incorporate adeno-associated virus (AAV) technologies developed by Wilson and […] The ...

Triple Ring Technologies Executive Wins International Innovation Award

Triple Ring Technologies, a leading research and development firm that partners with its clients to develop innovative products and to launch new businesses, announces today that their Vice President of Projects, Christina Sejr Pedersen, recently

Fresenius Kabi Receives 510(k) Clearance for the Fenwal Amicus® Red Blood Cell Exchange Protocol

Fresenius Kabi today announced it has received 510(k) clearance from the U.S. Food and Drug Administration for the Fenwal Amicus® Red Blood Cell Exchange (RBCx) system. Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The Fenwal Amicus R...

Human Rights Must be Front and Center for Artificial Intelligence, IoT, and Privacy

SOURCE: Cisco Systems Inc. DESCRIPTION:Artificial intelligence and the internet of things have the potential to drive unprecedented productivity, reduce pollution, and improve human health. With the rollout of advanced, high speed wireless connectivity known as 5G in the next few years, the number of connected devices will explode: 28.5 billion devices are expected to be networked by 2022 growing ...

Clinical Research And The Impact Of Blockchain

Clinical Research News | New technologies are developing that attempt to enhance the collaborative process between professionals across a plethora of industries. Blockchain is one technology that ignites this collaborative spirit.    

Philips introduces new premium digital X-ray room to help shorten patient wait times

Royal Philips , a global leader in health technology, has launched its DigitalDiagnost C90, a new ceiling-suspended digital radiography system. The system offers a live tube camera, versatile room configuration capabilities and exam automation technologies that work harmoniously to provide improved patient and Radiographer experiences.

IDT expands its courier zones in the UK

As an advocate for researchers in the genomics age, Integrated DNA Technologies (IDT) is expanding its courier zones to ensure that the highest-fidelity oligos are available in less time and at the same price, to more customers.

Alzheimer's Disease: Dynamic Market Forecast to 2026 [Report Updated: 09102018] Prices from USD $8495

Alzheimer's Disease: Dynamic Market Forecast to 2026SummaryAlzheimer's Disease AD is a rapidly evolving field in which new developments are constantly influencing the market landscape.The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the AD space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact...

Thursday 14th February 2019

Antigenic forms that lie in wait can be flushed out by sequencing and display technologies, or espied by high-resolution imaging -- http://ow.ly/1dbt30nHIyi 

Antigenic forms that lie in wait can be flushed out by sequencing and display technologies, or espied by high-resolution imaging -- http://ow.ly/1dbt30nHIyi 

Newly developed stem cell technologies show promise for treating PD patients

Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson's disease (PD) in future. Writing in a special supplement to the Journal of Parkinson's Disease, experts describe how newly developed stem cell technologies could be used to treat the disease and discuss the great promise, as well as the significant challenges, of stem cell treatment.

Graphene-based wearables for health monitoring, food inspection and night vision

(Graphene Flagship) The Graphene Pavilion, organised by the Graphene Flagship and supported by the European Commission and GSMA, is returning to Mobile World Congress (MWC) 2019 with over 20 graphene-based prototypes, four of which are developed by the Graphene Flagship partner ICFO, based in Barcelona. These technologies aim to turn mobile phones into life saving devices.

How gaming technologies can help cancer patients communicate better

(Lancaster University) Lancaster University is sharing in a €4m project to use gaming technology to improve the care of both adults and children with cancer.The project -- called 'MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems' funded by EU Horizon 2020, has 16 partners in seven countries.It aims to investigate the use of apps...

Digitalized infinity: Engineers present blockchain technology to verify natural diamonds

(National University of Science and Technology MISIS) Members of the Russian startup Bitcarat.com, graduates of the National University of Science and Technology MISIS, commercialize a unique technology, aimed at verifying and tracing natural diamonds. The method is based on modern IT-technologies, blockchain technology in particular. In a situation where natural, synthetic and fake stones exist i...

Synchrotron light to analyse mining waste in marine sediment in the Portman bay

(University of Barcelona) The light of ALBA Synchrotron will enable revealing the environmental impact of the tons of mining waste thrown for over forty years in the Portman bay (Murcia, Spain), as part of the research project by the Consolidated Research Group in Marine Geosciences of the Faculty of Earth Sciences of the University of Barcelona, which will apply new technologies to study one of t...

Synchrotron light to analyze mining waste in marine sediment in the Portman Bay

(University of Barcelona) The light of ALBA Synchrotron will enable revealing the environmental impact of the tons of mining waste thrown for over forty years in the Portman bay (Murcia, Spain), as part of the research project by the Consolidated Research Group in Marine Geosciences of the Faculty of Earth Sciences of the University of Barcelona, which will apply new technologies to study one of t...

Microfluidic techniques for enhancing biofuel and biorefinery industry based on microalgae

This review presents a critical assessment of emerging microfluidic technologies for the application on biological productions of biofuels and other chemicals from microalgae. Comparisons of cell culture desig...

Recent advances in lignin valorization with bacterial cultures: microorganisms, metabolic pathways, and bio-products

Lignin is the most abundant aromatic substrate on Earth and its valorization technologies are still under developed. Depolymerization and fragmentation are the predominant preparatory strategies for valorizati...

Patterson Companies Third-Quarter Fiscal 2019 Conference Call Scheduled for Thursday, February 28, 2019

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2019 third-quarter conference call on Thursday, February 28, 2019 at 9 a.m. CT (10 a.m. ET). The company’s earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company’s websit...

Axonics® to Report 2018 Fourth Quarter and Full-Year Financial Results and Host a Conference Call on March 5

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced that it will release financial results for the 2018 fourth quarter and full year aft...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks